1. Signatures of mutational processes in human cancer
- Author
-
Samuel Aparicio, Jessica Zucman-Rossi, Julia Richter, Stefan M. Pfister, Matthias Schlesner, Nikhil C. Munshi, Sean M. Grimmond, Andrew V. Biankin, Christine Desmedt, Rafael Valdés-Mas, Ton N. Schumacher, Elias Campo, Marina Pajic, Peter J. Campbell, Lucy R. Yates, David T. W. Jones, Laura van ’t Veer, Michael R. Stratton, Carlos Caldas, Matthew Meyerson, Hiromi Nakamura, Sandrine Boyault, Anne Vincent-Salomon, Keiran Raine, Peter Lichter, Marit M. van Buuren, Tomislav Ilicic, Stian Knappskog, Ultan McDermott, Sancha Martin, Andrew Tutt, Icgc PedBrain, Helen Davies, Barbara Hutter, Philip Rosenstiel, Sunil R. Lakhani, Marcin Imielinsk, John A. Foekens, Fumie Hosoda, Sandrine Imbeaud, Elli Papaemmanuil, David T. Jones, Nicola Waddell, Serena Nik-Zainal, Marcel Kool, Graham R. Bignell, Yasushi Totoki, Manasa Ramakrishna, Paul A. Northcott, Niccolo Bolli, Xose S. Puente, Adam Butler, Åke Borg, David C. Wedge, Jon W. Teague, Andrea L. Richardson, Reiner Siebert, Tatsuhiro Shibata, John V. Pearson, Carlos López-Otín, Angelo Paradiso, P. Andrew Futreal, Anne Lise Børresen-Dale, Sam Behjati, Birgit Burkhardt, Paul N. Span, Jorunn E. Eyfjord, Mel Greaves, Roland Eils, Ludmil B. Alexandrov, Natalie Jäger, Other departments, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Oncology, Medical Oncology, Pulmonary Medicine, Centre de Recherche en Automatique de Nancy (CRAN), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Centre Alexis Vautrin (CAV), and Centre National de la Recherche Scientifique (CNRS)-Université de Lorraine (UL)
- Subjects
Male ,0302 clinical medicine ,Neoplasms ,APOBEC Deaminases ,DNA Mutational Analysis ,MESH: Neoplasms ,MESH: Aging ,MESH: Models, Genetic ,MESH: DNA Mutational Analysis ,Exome ,MESH: Organ Specificity ,MESH: Mutagenesis ,Genetics ,0303 health sciences ,Multidisciplinary ,MESH: DNA ,MESH: Sequence Deletion ,3. Good health ,MESH: Reproducibility of Results ,Cell Transformation, Neoplastic ,030220 oncology & carcinogenesis ,Female ,DNA mismatch repair ,APOBEC ,MESH: Mutation ,Somatic hypermutation ,MESH: Algorithms ,Biology ,Article ,Quality of Care [ONCOL 4] ,03 medical and health sciences ,SDG 3 - Good Health and Well-being ,Translational research [ONCOL 3] ,Cytidine Deaminase ,MESH: Mutagens ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Humans ,ddc:610 ,MESH: Cytidine Deaminase ,030304 developmental biology ,MESH: Humans ,MESH: Transcription, Genetic ,MESH: Mutagenesis, Insertional ,Mutagenesis ,MESH: Cell Transformation, Neoplastic ,Evaluation of complex medical interventions [NCEBP 2] ,Kataegis ,Mutation ,Hormonal regulation Aetiology, screening and detection [IGMD 6] ,Human genome - Abstract
Item does not contain fulltext All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, 'kataegis', is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.
- Published
- 2013